Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 551 results for "clopidogrel"

Lower bleeding risk with cangrelor versus clopidogrelGPIs

medwireNews : Cangrelor is associated with a reduced risk for bleeding compared with clopidogrel plus routinely used glycoprotein IIb/IIIa inhibitors (GPIs) in patients undergoing percutaneous coronary intervention (PCI), results of a pooled ... MedWire News, 1 day ago

14 images for clopidogrel

Physician's Briefing, 3 weeks ago
HCPLive, 3 weeks ago, 3 weeks ago
Frontiers in Neurorobotics, 2 months ago
Frontiers in Neurorobotics, 2 months ago
Epoch Times, 4 months ago
Monthly Prescribing Reference, 5 months ago
Monthly Prescribing Reference, 7 months ago
Monthly Prescribing Reference, 7 months ago
MDLinx, 7 months ago

EUCLID: Ticagrelor, Clopidogrel in PAD Similar for CV Events

NEW ORLEANS, LA — Ticagrelor ( Brilinta/Brilique , AstraZeneca) did not prove to be superior to clopidogrel in patients with peripheral artery disease (PAD) in the Examining Use of Ticagrelor in PAD (EUCLID) trial, according to results presented ...
 Dermatology Online Journal3 weeks ago Ticagrelor vs. Clopidogrel in PAD  New England Journal of Medicine3 weeks ago EUCLID: Ticagrelor not superior to clopidogrel for CV event reduction in patients with PAD  Healio3 weeks ago No Ticagrelor Clinical Gain vs Clopidogrel in PAD: EUCLID  Dermatology Online Journal2 months ago

Clopidogrel Equivalent to Ticagrelor in Treatment of Peripheral Artery Disease: Presented at AHA

You currently are not registered for any FirstWord Pharma services. Register to FirstWord Pharma for free access to 10 articles every 30 days: You can also: Wait 14 days for your content allowance to be renewed. Sign up for a free trial to ...
 FirstWord Pharma2 weeks ago Ticagrelor versus Clopidogrel in Symptomatic Peripheral Artery Disease  New England Journal of Medicine3 weeks ago Ticagrelor Compared With Clopidogrel in Patients with Prior Lower Extremity Revascularization for Peripheral Artery Disease [Original Research Article]  Circulation3 weeks ago periphral artery disease clopidogrel is fine  HCPLive3 weeks ago

ABCC3 Polymorphisms and mRNA Expression Influence the Concentration of a Carboxylic Acid Metabolite in Patients on Clopidogrel and Aspirin Therapy

Abstract Acetylsalicylic acid and clopidogrel combined therapy has been reported to be beneficial in patients with acute coronary syndrome (ACS). Antiplatelet drug resistance, especially to clopidogrel, is a multifactorial phenomenon that affects ...
 Bionity.com3 weeks ago Prasugrel vs. Ticagrelor After Switch From Clopidogrel in CAD  General Medicine eJournal1 month ago TCT-107 Ticagelor is not superior to clopidogrel in patients with acute coronary syndrome A report from SCAAR  Journal of the American College of Cardiology1 month ago TCT-171 Effect of Ticagrelor Compared with Clopidogrel on Myocardial Infarct Size in Patients Undergoing Primary Percutaneous Coronary Intervention  Journal of the American College of Cardiology1 month ago

Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acu

Background Proton pump inhibitors (PPIs) reduce gastrointestinal bleeding events but may alter clopidogrel metabolism. We sought to understand the comparative effectiveness and safety of prasugrel versus clopidogrel in the context of proton pump ...
 AHA Journals - JAHA1 month ago CEO Adrian Adams Is Prepping Aralez For A Sale  Seeking Alpha3 weeks ago Pleasant Surprises Ahead For Aralez Pharmaceuticals' Shareholders  Seeking Alpha3 weeks ago Aralez's Yosprala shown to lower gastrointestinal risks  Stockwatch3 weeks ago

Factors Associated With Initial Prasugrel Versus Clopidogrel Selection for Patients With Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention: Insights From the Treatment With ADP Receptor Inhibitors: Longitudinal Assessment of Treatm

Background Few studies have examined how antiplatelet therapies are selected during the routine care of acute myocardial infarction patients, particularly relative to the patient's estimated mortality and bleeding risks. Methods and Results We ...
 Laryngoscope Investigative Otolaryngology2 months ago

UPDATE 2-AstraZeneca cuts Brilinta sales hopes on artery disease failure

* Brilinta fails to show benefit over clopidogrel in PAD * Follows failure of heart drug in stroke trial in March * Executive says $3.5 bln drug sales target not attainable * Drugmaker sells rights to Toprol-XL for up to $223 mln (Adds executive ...
 CNBC2 months ago UPDATE 1-AstraZeneca's Brilinta drug fails in big arterial disease trial  Business Insider2 months ago AstraZeneca cuts Brilinta sales hopes on artery disease failure  Yahoo! Finance UK and Ireland2 months ago AstraZeneca's Brilinta drug fails in big arterial disease trial  Yahoo! Finance2 months ago

Clopidogrel Market Analysis 2016-2021 with Industry Chain Structure, Competitive Landscape

India, Nov. 11, 2016 /PRNewswire-iReach/ -- 2016 Report - Global and Chinese Market Scenario offer a detailed market survey and an in-depth study of the overall Clopidogrel industry. The report comprehends of all major aspect of the industry, from ...
 International Business Times3 weeks ago Global and Chinese Clopidogrel Impurity Industry, 2016 Market Research Report  MarketResearch.com1 month ago Global ticagrelor market research report by end users (clinics, hospitals, medical institutions) forecast to 2027  SlideShare.net1 week ago

Human medicines European public assessment report (EPAR): Clopidogrel Krka, clopidogrel, Revision: 9, Authorised

This is a summary of the European Public Assessment Report (EPAR). It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the studies performed, to reach their recommendations on how to use the medicine. If you need ...
 European Medicines Agency2 weeks ago Investigators at RIKEN Report Findings in Clopidogrel Therapy (Clarification of the Mechanism of Clopidogrel-Mediated Drug-Drug Interaction in a...  4 Traders1 month ago
Physician's Briefing

GW27-e0776 Impacts of Different Serum Glucose Level on The Anti-Platelet Effect of Clopidogrel and Ticagrelor in Patients with Acute Myocardial Infarction Complicated by Type 2 Diabetes

 Journal of the American College of Cardiology1 month ago The Dogged Search for Cryptic Effects of Ticagrelor [Editorials]  Circulation1 week ago Platelet Transfusion Has Minimal Effect for Reversing Ticagrelor  Physician's Briefing2 months ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less